Home About Committee Contacts Links
  28.03.2025   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on March 28, 2025. 8 questions were reviewed at the meeting, including:
  • Materials of local clinical trials - 1
  • Materials of bioequivalence trials - 2
  • Supplemental materials to current clinical trials - 5
The following decisions were taken on these trials:
Approved without comments: 6
Approved subject to correction of problems and closure of comments on a routine basis: 2
 
  14.03.2025   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on March 14, 2025. 15 questions were reviewed at the meeting, including:
  • Materials of international multicenter clinical trials - 1
  • Materials of observational trials - 3
  • Materials of bioequivalence trials - 2
  • Supplemental materials to current clinical trials - 9
The following decisions were taken on these trials:
Approved without comments: 12
Approved subject to correction of problems and closure of comments on a routine basis: 3
 
  28.02.2025   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on February 28, 2025. 9 questions were reviewed at the meeting, including:
  • Materials of local clinical trials - 2
  • Materials of observational trials - 1
  • Supplemental materials to current clinical trials - 6
The following decisions were taken on these trials:
Approved without comments: 6
Approved subject to correction of problems and closure of comments on a routine basis: 3
 
  14.02.2025   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on February 14, 2025. 13 questions were reviewed at the meeting, including:
  • Materials of bioequivalence trials - 3
  • Materials of observational trials - 5
  • Supplemental materials to current clinical trials - 5
The following decisions were taken on these trials:
Approved without comments: 9
Approved subject to correction of problems and closure of comments on a routine basis: 4
 
  31.01.2025   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on January 31, 2025. 11 questions were reviewed at the meeting, including:
  • Materials of pharmacokinetic trials - 1
  • Materials of observational trials - 2
  • Supplemental materials to current clinical trials - 8
The following decisions were taken on these trials:
Approved without comments: 8
Approved subject to correction of problems and closure of comments on a routine basis: 2
Suspended: 1
 
  17.01.2025   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on January 17, 2025. 10 questions were reviewed at the meeting, including:
  • Materials of bioequivalence trials - 1
  • Materials of observational trials - 1
  • Materials of local clinical trials - 1
  • Supplemental materials to current clinical trials - 7
The following decisions were taken on these trials:
Approved without comments: 8
Approved subject to correction of problems and closure of comments on a routine basis: 2
 
  20.12.2024   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on December 20, 2024. 13 questions were reviewed at the meeting, including:
  • Materials of International Multicenter Clinical Trials - 1
  • Materials of observational trials - 3
  • Materials of local clinical trials - 1
  • Supplemental materials to current clinical trials - 8
The following decisions were taken on these trials:
Approved without comments: 10
Approved subject to correction of problems and closure of comments on a routine basis: 3
 
  06.12.2024   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on December 6, 2024. 10 questions were reviewed at the meeting, including:
  • Materials of observational trials - 3
  • Supplemental materials to current clinical trials -7
The following decisions were taken on these trials:
Approved without comments: 7
Approved subject to correction of problems and closure of comments on a routine basis: 2
Suspended: 1
 
  29.11.2024   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on November 29, 2024. 17 questions were reviewed at the meeting, including:
  • Materials of bioequivalence trials - 1
  • Materials of observational trials - 3
  • Materials of local trials - 1
  • Supplemental materials to current clinical trials -12
The following decisions were taken on these trials:
Approved without comments: 12
Approved subject to correction of problems and closure of comments on a routine basis: 5
 
  08.11.2024   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on November 8, 2024. 11 questions were reviewed at the meeting, including:
  • Materials of observational trials - 1
  • Supplemental materials to current clinical trials -10
The following decisions were taken on these trials:
Approved without comments: 6
Approved subject to correction of problems and closure of comments on a routine basis: 5
 
  25.10.2024   


Regular meeting of the Independent Multidisciplinary Committee on Ethical Review of Clinical Trials was held on October 25, 2024. 18 questions were reviewed at the meeting, including:
  • Materials of bioequivalence trials - 3
  • Materials of International Multicenter Clinical Trials - 2
  • Supplemental materials to current clinical trials -13
The following decisions were taken on these trials:
Approved without comments: 16
Approved subject to correction of problems and closure of comments on a routine basis: 2
 

 About us

 Committee regulations

 Members of the Committee

 Standard operating
procedures


 Document submitting policy

 Document list

 Terms and procedures of
undesirable effect reports



© 2010-2013 Universimed info@ethicuni.ru   Legal information   +7 (499) 943-94-58